They may inhibit pro-inflammatory cytokines, such as TNF-α, interleukin-17 (IL-17), or interleukin-33 (IL-33), thereby reducing inflammation and suppressing the immune-mediated processes involved in psoriasis. Here, IL33 is linked to psoriasis.